Skip to main content

The Significance and Interpretation of in Vitro Carcinogenicity Assay Results

  • Conference paper
Short-Term Test Systems for Detecting Carcinogens

Abstract

The major implication of discovering a new chemical carcinogen, whether synthetic of natural, is that it may present a carcinogenic risk to exposed populations. Only in cases where significant manufacturing or environmental human exposure to that chemical exists will a possible human carcinogenic hazard exist. It is therefore desirable that a system of hazard assessment should be devised. The above approach assumes that chemical carcinogens are easily and clearly definable — but such, of course, is not the case. One of the major causes of confusion in this area is the fear felt by many that insufficient or circumstantial evidence of carcinogenicity will be used to stimulate the response usually reserved for established human carcinogens. For example, few people would disagree with attempts to remove a recognizable source of potential hazard, such as the presence of a potent animal carcinogen in drinking water, but many would question whether abrupt action should be taken on finding that hamburgers contain chemicals mutagenic to S. typhimurium.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashby J, Styles JA, Paton D (1978) In vitro Evaluation of some derivatives of the carcinogen butter yellow: implications for environmental screening. Br J Cancer 38:34–50

    Article  PubMed  CAS  Google Scholar 

  2. Ashby J, Styles JA (1978) Comutagenicity, competitive enzyme substrates, and in vitro carcinogenicity assays. Mutat Res 54:105–112

    PubMed  CAS  Google Scholar 

  3. Ashby J, Styles JA, Anderson D, Paton D (1978) Saccharin: an epigenetic carcinogen mutagen? Fd Cosmet Toxicol 16:95–103

    Article  CAS  Google Scholar 

  4. Ashby J, Styles JA, Paton D (1978) Potentially carcinogenic analogues of the carcinogen hexamethylphosphoramide (HMPA). Br J Cancer 38:418–427

    Article  PubMed  CAS  Google Scholar 

  5. Ashby J, Anderson D, Styles JA (1978) The potential carcinogenicity of methyl fluorosulphonate (CH3OSO2F; Magic Methyl). Mutat Res 51:285–287

    Article  PubMed  CAS  Google Scholar 

  6. Ashby J, Purchase IFH (1977) The selection of appropriate chemical class controls for use with short-term tests for potential carcinogenicity. Ann Occup Hyg 20:297–301

    Article  PubMed  CAS  Google Scholar 

  7. Ashby J, Styles JA, Anderson D (1977) Selection of an in vitro carcinogenicity test for derivatives of the carcinogen hexamethylphosphoramide. Br J Cancer 36:564–571

    Article  PubMed  CAS  Google Scholar 

  8. Ashby J, Styles JA (1978) Does carcinogenic potency correlate with mutagenic potency in the Ames assay? Nature 271:452–455

    Article  PubMed  CAS  Google Scholar 

  9. Ashby J, Styles JA (1978) Does carcinogenic potency correlate with mutagenic potency in the Ames assay? Nature 274:19–22

    Article  Google Scholar 

  10. Ashby, J, Anderson D, Styles JA, Paton D (1978) Thiophene analogues of the carcinogens benzidine and 4-aminobiphenyl: evaluation in vitro. Br J Cancer 38:521–530

    Article  PubMed  CAS  Google Scholar 

  11. Purchase IFH, Longstaff E, Ashby J, Styles JA, Anderson D, Lefevre PA, Westwood FR (1978) An evaluation of six short-term tests for detecting organic chemical carcinogens. Br J Cancer 32:873–959 (in particular, Appendix I, 904–923)

    Google Scholar 

  12. Crabtree HG (1955) Retardation of azo-carcinogenesis by non-carcinogenic azo-compounds. Br J Cancer 9:310–317

    Article  PubMed  CAS  Google Scholar 

  13. Wattehberg LW (1978) Inhibitors of chemical carcinogenesis. Adv Cancer Res 26:197–226

    Article  Google Scholar 

  14. Moriya M, Kato K, Shirasu Y (1978) Effects of cysteine and liver metabolic activation system on the activities of mutagenic pesticides. Mutat Res 57:259–263

    Article  PubMed  CAS  Google Scholar 

  15. Rosin MP, Stich HF (1978) The inhibitory effect of cysteine on the mutagenic activities of several carcinogenesis. Mutat Res 54/73–81

    PubMed  CAS  Google Scholar 

  16. Yamamoto RS, Williams GM, Richardson HL, Weisburgher EK, Weisburgher JH (1978) Effects of p-hydroxyacetanilide on liver cancer induction by N-hydroxy-N-2-fluorenylacetamide. Cancer Res 33:454

    Google Scholar 

  17. Vesely DL, Levy GS (1978) Saccharin inhibits guanylate cyclase activity — possible relationship to carcinogenesis, Biochem Biophys Res Commun 81:1384

    Article  PubMed  CAS  Google Scholar 

  18. Kohli K, Venkitasubramanian TA (1978) Effect of dieldrin toxicity on pyridine nucleotides and activities of NADH and NADPH oxidase in rat liver. Chem Biol Interact 21:337–341

    Article  PubMed  CAS  Google Scholar 

  19. Nagao M, Yahagi T, Kawachi T, Sugimura T, Kosuge T, Tsuji K, Wakabayashi K, Mizusaki S, Matsumototo T (1977) Comutagenic action of norharman and harman. Proc Jpn Acad 53:95–98

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ashby, J. (1980). The Significance and Interpretation of in Vitro Carcinogenicity Assay Results. In: Norpoth, K.H., Garner, R.C. (eds) Short-Term Test Systems for Detecting Carcinogens. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67202-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67202-6_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67204-0

  • Online ISBN: 978-3-642-67202-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics